Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

HB 491 amends Tennessee law to add Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., and Sun Pharmaceutical Industries, Inc. to a list of companies that can be released from pending or future opioid-related claims by the attorney general. This changes two sections of Tennessee law (Title 20 and Title 33) to replace references to "The Kroger Co." with the new company names, affecting how these specific pharmaceutical firms may resolve legal claims. The bill does not create new liability but modifies existing release provisions for opioid-related cases. It directly impacts these three companies and the legal process for handling their opioid claims.